BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the medical technology company’s stock.

A number of other research analysts also recently weighed in on BIOL. Benchmark reiterated a “speculative buy” rating and set a $0.40 price target on shares of BIOLASE in a report on Wednesday, October 2nd. Ascendiant Capital Markets lowered their target price on BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd.

BIOLASE Price Performance

Shares of BIOL opened at $0.01 on Friday. The firm’s 50 day moving average is $0.05 and its 200-day moving average is $0.10. The stock has a market capitalization of $367,477.00, a P/E ratio of 0.00 and a beta of 0.67. BIOLASE has a 12-month low of $0.02 and a 12-month high of $1.94.

BIOLASE (NASDAQ:BIOL) last announced its earnings results on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share (EPS) for the quarter. BIOLASE had a negative net margin of 41.65% and a negative return on equity of 1,782.73%. The firm had revenue of $11.56 million for the quarter.

Institutional Trading of BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC lifted its stake in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the quarter. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 as of its most recent filing with the SEC. Institutional investors own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.